Jnana是一家创新药物研发商，重点是开发靶向溶质载体（SLC）转运蛋白家族的创新药物，SLC转运蛋白被称为细胞的“代谢门控” ，一般表达在细胞膜 ...

日本大冢制药（Otsuka Pharmaceutical）周四表示，将斥资逾10亿美元收购总部位于美国的Jnana Therapeutics，以扩大其药物组合。 该公司在一份声明中表示 ...

The Karnataka government is planning to build a 2-km-long elevated road over the Bangalore University (BU) campus at Jnana ...

Jnana Therapeutics Inc. has identified sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of diabetes, chronic kidney disease, ...

BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging ...

Jnana Therapeutics is hitting early-stage momentum, adding additional validation in the form of new cash and a fresh Big Pharma collaboration just as its lead metabolic disease asset launches into ...

Otsuka Pharmaceutical plans to buy Jnana Therapeutics for $800 million in cash, gaining access to the privately held biotech’s drug discovery platform and an experimental medicine that’s ...

BOSTON--(BUSINESS WIRE)--Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets ...

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a ...

Like Walgude, hundreds of women in and around Velhe are aware of how low Hb affects their body, thanks to a seven-year-long blood testing campaign conducted by Jnana Prabodhini, an institution ...